Skip To Main Content
Werner Rabitsch on Muck Rack

Werner Rabitsch

As seen in: Color Research & Application, Nature, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Werner Rabitsch’s profile

Articles by Werner Rabitsch

Lung transplantation after allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT

|
By Juan Montoro, Saskia Bos, Christophe Peczynski, Manuela Badoglio, Robin Vos, Tobias Gedde-Dahl, Mahmoud Aljurf, Werner Rabitsch, David Ma, Jaime Sanz, Ana Bataller, Johannes Schetelig, Martin Kolditz, Anna Paola Iori, Christian Koenecke, Mar Bellido, Robert Zeiser, Montserrat Rovira, Rabah Redjoul, Frédéric Schlemmer, Ivan S. Moiseev, Zina Peric, Olaf Penack, Helene M. Schoemans, Pascale Ambron, Adrian Havryk, Harshita Rajasekariah, Jens Gotlieb, Angela Figuera
| Nature Verified
Abstract Late-onset non-infectious pulmonary complications (LONIPCs) are severe late complications after allogeneic hematopoietic cell transplantation (HCT), associated with high morbidity and mortality. Lung transplantation (LT) may offer a survival benefit, but is infrequently performed due to concerns regarding outcomes. We conducted a retrospective multicenter study of adult patients who underwent LT for LONIPCs after HCT between 2000 and 2019. Thirty-one centers contributed clinical data.
Open in Who Shared Issue with article?

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party

|
By Diderik-Jan Eikema, Linda Koster, Joe Tuffnell, Alexander Kulagin, Jan Vydra, Nicolaus Kröger, Khaled Halahleh, Elena Parovichnikova, He Huang, Victoria Potter, Tobias Gedde-Dahl, Péter Reményi, Jakob Passweg, Mariya Koc, Ben Carpenter, Werner Rabitsch, Raffaella Cerretti, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal McLornan
| Nature Verified
Abstract Myelodysplastic syndromes (MDS) in young adults are uncommon and underrepresented in transplant cohorts. We evaluated 697 patients aged 18–40 years who underwent first allogeneic hematopoietic cell transplantation (allo-HCT) reported to the EBMT between 2016 and 2021. The primary endpoint was overall survival (OS); secondary endpoints included progression-free survival (PFS), cumulative incidence of relapse (CIR), non-relapse mortality (NRM), and graft-versus-host disease (GVHD).
Open in Who Shared Issue with article?

Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT

|
By Ryszard Swoboda, Myriam Labopin, Nicolaus Kröger, Matthias Stelljes, Thomas Schroeder, Peter Dreger, Gesine Bug, Andrew McDonald, Montserrat Rovira, Igor Wolfgang Blau, Desiree Kunadt, Regis de Latour, Werner Rabitsch, Matthias Eder, Marie Therèse Rubio, Alexandros Spyridonidis, Zinaida Perić, Sebastian Giebel, Mohamad Mohty Verified, Fabio Ciceri, Tülay Özçelik
| Nature Verified
Abstract There are very limited data on treosulfan (Treo)-based conditioning before allogeneic hematopoietic stem cell transplantation (alloHSCT) in acute lymphoblastic leukemia. We aimed to compare fludarabine with Treo (FluTreo) or total body irradiation (FluTBI) in this setting. The final matched-pair analysis included ALL patients transplanted in complete remission after FluTreo (n = 153) or FluTBI (n = 431). The median patient age was 56.5 and 54.1 years, respectively.
Open in Who Shared Issue with article?

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study

|
By Simon Renders, Maud Ngoya, Laurence de Leval, Rachael Pocock, Ron Ram, Tobias Gedde-Dahl, Yasmina Serroukh, Gesine Bug, Nicolaus Kröger, Arnon Nagler, Thomas Pabst, Werner Rabitsch, Ibrahim Yakoub-Agha, Matthias Eder, Siret Ratip, Christoph Scheid, José Antonio Pérez-Simón, Eva Wagner-Drouet, Anna Sureda, Norbert Schmitz, Bertram Glass, Ali Bazarbachi, Peter Dreger, Herve Finel, Irma Khvedelidze
| Nature Verified
Abstract To the Editor T-cell/histiocyte-rich LBCL (THRLBCL) is an uncommon entity within the large B-cell lymphoma family, comprising less than 5% of all LBCL [1]. Compared to other LBCL, THRLBCL patients are younger, commonly male, present with higher International Prognostic Indexes (IPI), and advanced disease stages [2]. THRLBCL is named for its unique immunomodulating micro-milieu characterized by T-cell and histiocyte infiltration.
Open in Who Shared Issue with article?

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT

|
By Annalisa Paviglianiti, Maud Ngoya, Thomas Schroeder, Péter Reményi, Linde M. Morsink, Jaime Sanz, Ladislav Sopko, Francis Ayuk, Mareike Verbeek, Tessa Kerre, Matthias Eder, Pavel Zak, Pascal Turlure, Mieke Roeven, Alexander Kulagin, Alessandro Maggi Verified, Ron Ram, Alessandro Busca, Werner Rabitsch, Dominik Schneidawind, Eolia Brissot, Fabio Ciceri, Regis Peffault de la Tour, Mareike Durholt, Ibrahim Yakoubagha
| Nature Verified
Abstract Limited data is available on outcomes of mixed phenotype acute leukemia (MPAL) following allogeneic stem cell transplantation (HCT), and the impact of haploidentical HCT with post-transplant cyclophosphamide in this setting is lacking. We retrospectively analyzed 195 adults with MPAL undergoing HCT in first complete remission from 2014 to 2023. The 2-year overall survival (OS) and leukemia free survival (LFS) were 70.7% and 56.4%.
Open in Who Shared Issue with article?

Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT

|
By Alexandros K. Kanellopoulos, Linda Koster, Hugues de Lavallade, Guillermo Orti, Sebastian Francis, Jakob Passweg, Jane F. Apperley, Wolfgang Andreas Bethge, Werner Rabitsch, Jennifer Clay, Edouard Forcade, Erin Hurst, Caroline Besley, Francesca Kinsella, Mahmoud Aljurf, He Huang, Aloysius Ho, Inken Hilgendorf, Goda Choi, Francis Ayuk, Matthias Stelljes, Deborah Richardson, Elena Morozova, Witold Prejzner, Robert Zeiser, Christopher Armstrong, Kavita Raj, Joanna Drozd-Sokolowska, Yves Chalandon, Donal McLornan, Helbig Grzegorz
| Nature Verified
Abstract The landscape of Allogeneic Haematopoietic Cell Transplantation (allo-HCT) for Chronic Myeloid Leukaemia (CML) remains dynamic with the advent of tyrosine kinase inhibitors (TKIs). There remains an absence of widely agreed evidence-based guidelines for post-transplant monitoring and relapse management.
Open in Who Shared Issue with article?

Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

|
By Simone Cesaro, Chiara Garonzi, Gloria Tridello, Inge Verheggen, Daihong Liu, Catherine Flynn, Ali Alahmari, Leylagül Kaynar, Werner Rabitsch, Vedat Uygun, Pedro Chorão, Jiong Hu, Albert Esquirol, José Luis Piñana, Mahmoud Aljurf, Eva Wagner-Drouet, Peter Lang, Guillermo Martín-Sánchez, Barbara Nasilowska-Adamska, Jan Styczynski, Ron Ram, Elisabetta Metafuni, Alina Doina Tanase, Krzysztof Kalwak, Bianca Serio, Hasan Hashem, Luca Castagna, Marta González Vicent, Musa Karakukcu, Ioannis Baltadakis, Edoardo Benedetti, Malgorzata Mikulska, Rafael de la Camara, Dina Averbuch, Siret Ratip, Luca Facchini, Khaled Halahleh
| Nature Verified
Hemorrhagic cystitis (HC) is a frequent complication after hematopoietic cell transplant (HCT), with an incidence ranging from 2 to 66% depending on the type of transplant and the age of the patient [1,2]. In the last two decades, the use of post-transplant cyclophosphamide (PT-Cy) as graft-versus-host-disease (GVHD) prophylaxis has been associated with an increased incidence of HC [3,4].
Open in Who Shared Issue with article?

Vaccines | Free Full-Text | Influence of Acute and Chronic Graft-Versus-Host Disease on Persistence of Antibodies against Measles, Mumps, Rubella and Varicella in the First Year after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

|
By Nicole Harrison, Heinz Burgmann, Werner Rabitsch, Claudia Honsig
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open in Who Shared Issue with article?

A bi‐centric experience of extracorporeal carbon dioxide removal (ECCO2R) for acute hypercapnic respiratory failure following allogeneic hematopoietic stem cell transplantation

|
By Philipp Wohlfarth, Peter Schellongowski, Thomas Staudinger, Werner Rabitsch
| Wiley Online Library Verified
MAIN TEXT Philipp Wohlfarth Corresponding Author philipp.wohlfarth@meduniwien.ac.at orcid.org/0000-0001-5628-7942 Hematopoietic Stem Cell Transplantation Unit, Austria Correspondence to: Philipp Wohlfarth, Hematopoietic Stem Cell Transplantation Unit, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18‐20, 1090 Vienna, Austria Email: philipp.wohlfarth@meduniwien.ac.at Search for more papers by this author Tobias Liebregts Department of Bone Marrow Transplantation,...
Open in Who Shared Issue with article?
Show More